Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,225
Closed -$1.25M 64
2020
Q2
$1.25M Sell
3,225
-5,882
-65% -$2.2M 0.01% 56
2020
Q1
$2.86M Hold
9,107
0.03% 48
2019
Q4
$3.34M Hold
9,107
0.02% 54
2019
Q3
$2.33M Buy
9,107
+3,139
+53% +$880K 0.02% 49
2019
Q2
$1.58M Buy
+5,968
New +$1.51M 0.01% 49
2017
Q1
Sell
-1,308,615
Closed -$267M 68
2016
Q4
$267M Buy
1,308,615
+16,279
+1% +$3.1M 1.91% 21
2016
Q3
$229M Buy
1,292,336
+357,119
+38% +$62M 1.6% 21
2016
Q2
$168M Buy
935,217
+726,364
+348% +$129M 1.28% 23
2016
Q1
$38.2M Buy
+208,853
New +$36.2M 0.31% 46

Other funds holding HUM

Orbis Allan Gray's HUM Position: Q3 2020 in Review

Orbis Allan Gray sold out of Humana (HUM) in Q3 2020, closing a stake of 3,225 shares — an estimated $1.25M sold.

Orbis Allan Gray first reported a position in HUM in Q1 2016 and held it in 9 quarters. The position peaked at $267M in Q4 2016. 847 funds tracked by Wall St. Rank hold HUM as of Q3 2020.

  • Orbis Allan Gray reported no remaining Humana position as of Q3 2020 after selling out during the quarter.
  • Orbis Allan Gray sold 3,225 Humana shares in Q3 2020, an estimated $1.25M.
  • Orbis Allan Gray first reported a position in Humana in Q1 2016 and held it in 9 quarters.
  • Orbis Allan Gray's Humana position peaked at $267M in Q4 2016.
  • 847 funds tracked by Wall St. Rank held Humana as of Q3 2020.

Based on Orbis Allan Gray's 13F filing for Q3 2020, filed 16 Nov 2020.